Loading...
Dernières publications
-
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-Da-Cruz, et al.. T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology, 2023, 14, pp.120283. ⟨10.3389/fimmu.2023.1202834⟩. ⟨hal-04603915⟩
-
Fanny Roth, Jamila Dhiab, Alexis Boulinguiez, Hadidja-Rose Mouigni, Saskia Lassche, et al.. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy. Acta Neuropathologica, 2022, ⟨10.1007/s00401-022-02503-7⟩. ⟨hal-03832636⟩
-
Elisa Negroni, Maria Kondili, Laura Muraine, Mona Bensalah, Gillian Sandra Butler-Browne, et al.. Muscle fibro-adipogenic progenitors from a single-cell perspective: Focus on their “virtual” secretome. Frontiers in Cell and Developmental Biology, 2022, 10, ⟨10.3389/fcell.2022.952041⟩. ⟨hal-03830589⟩
Chiffres clés
103
Publications avec texte intégral
Open Access
61 %
Mots clés
AAV
Amyotrophic Lateral Sclerosis
Autoimmune diseases
Epigenetics
Annexin A2
PABPN1 agregates
Muscle stem cells
Human
APOPTOSIS
Haploinsufficiency
BINDING SPECIFICITY
Ageing
Satellite cell
Metabolism
Atrophy
Alzheimer's disease
ARN
Transcriptomics
AAV vectors
GENE
Regeneration
Neuromuscular junction NMJ
Actin
Inflammation
Triplet expansion disease
Arbovirus
Dysferlinopathy
OPMD
Myoblasts
Myoblast
Differentiation
Geriatric assessment
Muscle strength
AChR antibodies
Regulatory T cells
Akt
Gene replacement
Pax7
Myositis
Duchenne muscular dystrophy
Oculopharyngeal muscular dystrophy
Calcium
Bile salt hydrolases
Omics
Myogenesis
AUTOPHAGY
Intercellular communication
FAPs
Myopathies
ALS
Neuromuscular disease
Pharyngeal muscle
Biomarker
Xenograft
Aged
Antiserum
Accelerometry
Muscular dystrophy
Adipose tissue
Nuclear envelope
Alphavirus
Functional genomics
DMD
Myopathy
Muscle
Muscle fibrosis
Autologous
Fibrosis
Skeletal muscle
MUTATIONS
Sarcopenia
Andermann syndrome
Agrégats de PABPN1
Dystrophin
Antisens oligonucleotides
Gene therapy
Regenerative medicine
Exon-skipping
Thérapie génique
Anti-fibrotic pharmacotherapies
Satellite cells
Effector T cells
PABPN1
RNA
Lamins
Cell therapy
Dysferlin
Myosin
FSHD
DNA methylation
Cross-bridge kinetics
Mass spectrometry
Aav-U7
Myotube
Muscle dystrophy
Aggregate
Anti-acetylcholine receptor antibodies
Dystrophie musculaire oculopharyngée
DUX4
2-D PAGE